Are you on dialysis, taking blood thinners, and need an interventional radiology procedure?
https://libcat.nshealth.ca/en/permalink/chpams35344
Nova Scotia Health Authority. QEII. Pharmacy Services, Nova Scotia Health Authority. QEII. Vascular Access Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1444
- Available Online
- View Pamphlet
This pamphlet gives directions for dialysis patients on warfarin who are having an interventional radiology procedure. The pamphlet explains what an interventional radiology procedure is. Space is provided to write the name and date of your procedure, as well as instructions to follow before and after your procedure. Instructions about what to do if you notice any bleeding or bruising in the area of your body where the procedure was done are included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Pharmacy Services
- Nova Scotia Health Authority. QEII. Vascular Access Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Nephrology
- Warfarin
- Renal Dialysis
- Radiology, Interventional
- Subjects (LCSH)
- Nephrology
- Hemodialysis
- Warfarin
- Interventional radiology
- Specialty
- Nephrology
- Abstract
- This pamphlet gives directions for dialysis patients on warfarin who are having an interventional radiology procedure. The pamphlet explains what an interventional radiology procedure is. Space is provided to write the name and date of your procedure, as well as instructions to follow before and after your procedure. Instructions about what to do if you notice any bleeding or bruising in the area of your body where the procedure was done are included.
- Notes
- Previous title: Hemodialysis instead of dialysis
- Previous title: Dialysis patients on Warfarin who need interventional radiology procedures
- Responsibility
- Prepared by: Pharmacy Services, Vascular Access Services
- Pamphlet Number
- 1444
Oral Anticoagulation Therapy : Cases and Clinical Correlation
https://libcat.nshealth.ca/en/permalink/provcat41753
Kathryn Kiser, editor.
--Cham:
Springer
, 2017.
- Available Online
- View e-Book
- Location
- Online
This case-based title reviews anticoagulation management strategies available for a wide variety of clinical scenarios. Designed to aid providers of direct patient care on complex clinical decisions regarding appropriate evidence-based therapy options, patient and agent related variables to consider, as well as expert opinion on the topic. Oral Anticoagulation Therapy: Cases and Clinical Correlation will provide clinicians and trainees with clear clinical cases, commentary, and resources to dev…
- Available Online
- View e-Book
- Other Authors
- Kiser, Kathryn
- Responsibility
- Kathryn Kiser, editor
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- 2017
- Physical Description
- 1 online resource (x, 313 pages) : 6 illus., 2 illus. in color
- ISBN
- 9783319546438
- 9783319546414 (print ed.)
- Subjects (MeSH)
- Administration, Oral
- Anticoagulants - therapeutic use
- Hemorrhage - drug therapy
- Vascular Diseases - drug therapy
- Warfarin - therapeutic use
- Abstract
- This case-based title reviews anticoagulation management strategies available for a wide variety of clinical scenarios. Designed to aid providers of direct patient care on complex clinical decisions regarding appropriate evidence-based therapy options, patient and agent related variables to consider, as well as expert opinion on the topic. Oral Anticoagulation Therapy: Cases and Clinical Correlation will provide clinicians and trainees with clear clinical cases, commentary, and resources to develop their knowledge base, problem-solving skills, and ability to practically apply new knowledge to a variety of clinical situations. Resources provided in cases include valuable figures, tables, and key points designed for the reader to be able to utilize at the point of care.
- Contents
- Part I: Introduction -- 1. Introduction -- Part II: Atrial Fibrillation -- 2. CHA2DS2-VASc and HAS-BLED Risk Stratification Tools -- 3. Male with Priority of Ischemic Stroke Reduction -- 4. Choosing an Anticoagulant in an Elderly Patient -- 5. Patient with Prior History of GI Hemorrhage -- 6. Patients with a History of Intracranial Hemorrhage -- 7. Concerns with Anticoagulant Adherence -- 8. Oral Anticoagulants in Stable Moderate Chronic Kidney Disease -- 9. Oral Anticoagulants in Severe Renal Dysfunction -- 10. Oral Anticoagulants in Patients with Variable Renal Function -- 11. Patient with Concomitant Stable Coronary Artery Disease -- 12. Patient with Concomitant Acute Venous Thromboembolism -- 13. Patient with Concomitant Mitral Valve Stenosis -- 14. Patient with Concomitant Aortic Valve Stenosis -- Part III: Warfarin Management -- 15. Best Practice for Switching Stable Warfarin Patients -- 16. Patient-Centered Strategies for Improving Warfarin Management -- Part IV: Venous Thromboembolism (VTE) -- 17. Provoked Versus Unprovoked Venous Thromboembolism -- 18. Venous Thromboembolism (VTE) Prophylaxis in Hip and Knee Replacement Surgery -- 19. Venous Thromboembolism (VTE) Prophylaxis in the Intensive Care Unit (ICU) -- 20. VTE and Recent Drug Eluting Stent (DES) Placement -- 21. Acute VTE in a Patient with Moderate Chronic Kidney Disease -- 22. Oral Anticoagulation and Duration in Recurrent Venous Thromboembolism (VTE) -- 23. Pulmonary Embolism (PE) with Thrombolytic Therapy -- Part V: Acute Coronary Syndrome (ACS) -- 24. Patient on Oral Anticoagulant Presenting with ACS -- 25. Oral Anticoagulant Therapy Post-Percutaneous Coronary Intervention -- 26. ST-Segment Elevation Myocardial Infarction (Lytic Candidate) on Oral Anticoagulant -- 27. ACS with Bypass Surgery -- Part VI: Drug Interactions -- 28. Anticoagulant Drug-Drug Interactions with CYP 3A4 Inhibitors -- 29. Significance of P-glycoprotein (P-gp) Drug-Drug Interactions -- 30. Considerations with Pharmacodynamic Drug-Drug Interactions -- 31. Management of Direct Oral Anticoagulants with Mixed P-gp/3A4 Drug-Drug Interactions -- 32. Pharmacokinetic Drug-Drug Interactions with Warfarin -- Part VII: Special Populations -- 33. Chronic Pain Management with Anticoagulation -- 34. Anticoagulation Management in Atrial Fibrillation Catheter Ablation -- 35. Anticoagulation Management Considerations for Mechanical Valves -- 36. Management of Antiphospholipid Antibody Syndrome -- 37. Venous Thromboembolism and Pregnancy -- 38. Venous Thromboembolism in Active Malignancy -- 39. Anticoagulation Management in Patients Undergoing Gastric Bypass Procedures -- 40. Patient Presenting with Minor Bleeding -- 41. Patient Presenting with Major, Life-Threatening Bleeding -- 42. Overdose of Dabigatran.
- Format
- e-Book
- Location
- Online
Warfarine sodique
https://libcat.nshealth.ca/en/permalink/chpams36661
Nova Scotia Health Authority. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 2063
- Available Online
- View Pamphlet
Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également f…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Services
- Alternate Title
- Coumadin
- Warfarin sodium
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- French
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Warfarin
- Anticoagulants
- Subjects (LCSH)
- Warfarin
- Anticoagulants (Medicine)
- Abstract
- Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également fournies sur la façon de prendre le médicament, les doses manquées, les analyses sanguines RIN (ou INR), les interactions médicamenteuses et alimentaires, les effets secondaires et les mesures de sécurité. Vous y trouverez aussi des numéros où appeler si vous avez des questions.
- This is a French translation of the English pamphlet 0373 “Warfarin Sodium". This pamphlet gives specific directions if you are a patient on warfarin and you are undergoing treatment for at least one of the following conditions: atrial fibrillation (irregular heartbeat), prosthetic (artificial) heart valve, venous thrombosis (blood clot in a deep vein) or pulmonary embolism (artery in the lung blocked by a blood clot), myocardial infarction (heart attack), or another related condition. Directions about how to take this medication, missed doses, INR blood tests, drug and food interactions, side effects, and safety precautions are provided. Contact numbers are also given if you have questions.
- Responsibility
- Prepared by: Pharmacy Services ; Revised by: Hematology Services, QEII
- Pamphlet Number
- 2063
Warfarin sodium
https://libcat.nshealth.ca/en/permalink/chpams36501
Nova Scotia Health Authority. QEII. Pharmacy Services, Nova Scotia Health Authority. QEII. Hematology Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 0373
- Available Online
- View Pamphlet
Warfarin sodium is a type of medication called an oral (by mouth) anticoagulant. An anticoagulant makes your blood less likely to clot (thicken into a clump). This medication helps to prevent and treat abnormal blood clotting. This pamphlet explains what warfarin sodium is, why you may need it, how to take it, and what to do if you miss a dose. Information about INR blood tests, drug and food interactions, possible side effects, and safety precautions is included. Contact information for the An…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Pharmacy Services
- Nova Scotia Health Authority. QEII. Hematology Services
- Alternate Title
- Coumadin
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Warfarin
- Anticoagulants
- Subjects (LCSH)
- Warfarin
- Anticoagulants (Medicine)
- Specialty
- Medications
- Abstract
- Warfarin sodium is a type of medication called an oral (by mouth) anticoagulant. An anticoagulant makes your blood less likely to clot (thicken into a clump). This medication helps to prevent and treat abnormal blood clotting. This pamphlet explains what warfarin sodium is, why you may need it, how to take it, and what to do if you miss a dose. Information about INR blood tests, drug and food interactions, possible side effects, and safety precautions is included. Contact information for the Anticoagulation Clinic and the Thrombosis Anticoagulation Program is provided. The French translation of this pamphlet 2063, "Warfarine sodique" is also available.
- Notes
- Previous title: Warfarin sodium, an oral anticoagulant
- Responsibility
- Prepared by: Pharmacy Services and Hematology Services, QEII
- Pamphlet Number
- 0373
